![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
381 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
JAMA Clinical Reviews JAMA Network
-
- Health & Fitness
-
-
4.5 • 422 Ratings
-
Author interviews that explore the latest clinical reviews.
-
Heat-Related Illness and Athletes
Exertional heat illness at its extreme may cause heat stroke and altered mental status (confusion, delirium, stupor, or unconsciousness), which can result in organ failure and death. Author Francis G. O’Connor, MD, MPH, discusses heat-related illness in athletes, including risk factors, prevention, symptoms, and management, with JAMA Associate Editor David Simel, MD, MHS. Current NWS Forecast
Related Content:
Heat-Related Illness in Athletes -
Obesity Medications
New weight-loss drugs have transformed care for people with obesity. In this Clinical Reviews podcast, Robert F. Kushner, MD, MS, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss prescribing these drugs to improve health outcomes and minimize adverse effects in people with obesity.
Related Content:
Medications for Obesity -
Medical Practice and Climate Change
Medical practice accounts for 8% of carbon emissions in the US. Author Wendy Levinson, MD, discusses simple changes that clinicians can make to reduce adverse effects of health care on the climate and the environment with JAMA Deputy Editor Mary McGrae McDermott, MD.
Related Content:
Medical Practice and the Climate Crisis How Can Operating Rooms Be Greener? -
Essential Tremor
Essential tremor is a common movement disorder. Author Binit B. Shah, MD, of the University of Virginia joins JAMA Deputy Editor Christopher C. Muth, MD, to discuss the diagnostic evaluation and treatment of essential tremor, including pharmacological, nonpharmacological, and surgical treatments.
Related Content:
Essential Tremor -
Why Should Insurers Care About Clinical Trials?
The US is a global leader in introducing new medical products, but the ability to generate evidence to inform clinical practice in postmarket settings must improve. Insurers may have an important role to play. Robert M. Califf, MD, of the US Food and Drug Administration, discusses why and how payers could support evidence generation with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.
Related Content:
Why Evidence Generation Should Matter to Payers and How They Can Help -
Update: Diagnosis and Management of Celiac Disease
What are the common signs and symptoms of celiac disease and how is this disease diagnosed and managed? Author Kerstin Austin, MD, from the University of Wisconsin-Madison, discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS.
Related Content:
Diagnosis and Management of Celiac Disease
Customer Reviews
Bill Brandenburg, MD, Full Scope
Most episodes great. Just listened to IBS. No mention of diet, exercise, or even fiber. Very little on stress. A bunch of marginal drugs mentioned. Try looking at the forest through the trees. Wake up to the effects of lifestyle on health.
Maternal mortality
Political opinions inserted into a mortality conversation…. No thanks
Crap woke company
AMA’s head so far up it’s own butt it can’t see how horrible an organization it’s become. Attacks it’s own people such as Ed Livingston and forces him to resign over some bull controversy. I’ll never support them again.